Sriya Sreekanth

Sriya Sreekanth is a graduate student at The Ohio State University since August 2023, following a role as a Research Associate II at Entrada Therapeutics from October 2020 to July 2023. Prior experience includes a research internship at Protein Design Private Limited focused on expression studies of glycosylated proteins in mammalian and bacterial cells, and a summer research internship in the Bio-medicine Department at Pfizer, where work centered on bispecific antibodies for cancer therapy. Additionally, Sriya interned in the Regulatory Department at Stelis Biopharma, preparing a regulatory guideline workbook and evaluating regulatory procedures for numerous countries in Europe and America. Sriya holds a Bachelor’s degree in Biotechnology from Vellore Institute of Technology, completed in 2020.